What amount sold does Neuro-Innovators LLC report in Form D filings?

The latest linked filings report $640K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Neuro-Innovators LLC's most recent SEC filing?

Neuro-Innovators LLC's most recent Form D filing was on 2025-02-18.

How many investors does Neuro-Innovators LLC have?

The most recent Form D filing lists 6 investor(s).

What type of securities does Neuro-Innovators LLC offer?

Neuro-Innovators LLC's SEC Form D filings indicate equity offerings.

Neuro-Innovators LLC

CIK: 0001960774·Pharmaceuticals·SEWICKLEY, PA·Corporation·Founded 2021

Reported Sold

$640,183

Total Filings

Identified Offerings

Last Filed

Feb 18, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Feb 18, 2025Form D — New notice

Reported sold: $540,183 · Target: $3,390,172

Rule 506(b)·6 investors

Jan 4, 2023Form D — New notice

Reported sold: $100,000 · Target: $1,900,000

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$640,183

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

John Howison Schroeder

Related Person

Appears on 2 filings

Peter C. Doyle

Related Person

Appears on 1 filing

Blynn L. Schideler

Related Person

Appears on 1 filing

Mark Cochran

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Feb 18, 2025	New	$3,390,172	$540,183	6
Jan 4, 2023	New	$1,900,000	$100,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Duo Oncology Inc.

Pharmaceuticals

Offering target: $3,500,000

Filed Aug 7, 2026